ANI Pharmaceuticals has launched Prucalopride Tablets, a generic version of Motegrity, after receiving FDA approval and a Competitive Generic Therapy (CGT) designation.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.